The global magnetic resonance imaging market size accounted for USD 8.15 billion in 2024, grew to USD 8.47 billion in 2025 and is predicted to surpass around USD 11.95 billion by 2034, representing a healthy CAGR of 3.91% between 2024 and 2034. The North America magnetic resonance imaging market size is calculated at USD 3.18 billion in 2024 and is expected to grow at a fastest CAGR of 4.02% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Magnetic Resonance Imaging Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Magnetic Resonance Imaging Market, by Architecture, 2024-2034
8.1.1. Closed system
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Open system
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Magnetic Resonance Imaging Market, by Type, 2024-2034
9.1.1. Conventional
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Bio-based
9.1.2.1. Market Revenue and Forecast (2021-2034)
10.1. Magnetic Resonance Imaging Market, by Process, 2024-2034
10.1.1. Trans-Esterification
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Direct Esterification
10.1.2.1. Market Revenue and Forecast (2021-2034)
11.1. Magnetic Resonance Imaging Market, by Field Strength, 2024-2034
11.1.1. Mid field strength
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Low field strength
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. High field strength
11.1.3.1. Market Revenue and Forecast (2021-2034)
12.1. Magnetic Resonance Imaging Market, by Application, 2024-2034
12.1.1. High field strength
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Brain and neurological
12.1.2.1. Market Revenue and Forecast (2021-2034)
12.1.3. Spine and musculoskeletal
12.1.3.1. Market Revenue and Forecast (2021-2034)
12.1.4. Vascular
12.1.4.1. Market Revenue and Forecast (2021-2034)
12.1.5. Abdominal
12.1.5.1. Market Revenue and Forecast (2021-2034)
12.1.6. Cardiac
12.1.6.1. Market Revenue and Forecast (2021-2034)
12.1.7. Breast
12.1.7.1. Market Revenue and Forecast (2021-2034)
12.1.8. Others
12.1.8.1. Market Revenue and Forecast (2021-2034)
13.1. Magnetic Resonance Imaging Market, by End User, 2024-2034
13.1.1. Imaging centers
13.1.1.1. Market Revenue and Forecast (2021-2034)
13.1.2. Hospitals
13.1.2.1. Market Revenue and Forecast (2021-2034)
13.1.3. Ambulatory surgical centers
13.1.3.1. Market Revenue and Forecast (2021-2034)
13.1.4. Others
13.1.4.1. Market Revenue and Forecast (2021-2034)
14.1. North America
14.1.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.1.2. Market Revenue and Forecast, by Type (2021-2034)
14.1.3. Market Revenue and Forecast, by Process (2021-2034)
14.1.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.1.5. Market Revenue and Forecast, by Application (2021-2034)
14.1.6. Market Revenue and Forecast, by End User (2021-2034)
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.1.7.2. Market Revenue and Forecast, by Type (2021-2034)
14.1.7.3. Market Revenue and Forecast, by Process (2021-2034)
14.1.7.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.1.8. Market Revenue and Forecast, by Application (2021-2034)
14.1.8.1. Market Revenue and Forecast, by End User (2021-2034)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.1.9.2. Market Revenue and Forecast, by Type (2021-2034)
14.1.9.3. Market Revenue and Forecast, by Process (2021-2034)
14.1.9.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.1.10. Market Revenue and Forecast, by Application (2021-2034)
14.1.11. Market Revenue and Forecast, by End User (2021-2034)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.2.2. Market Revenue and Forecast, by Type (2021-2034)
14.2.3. Market Revenue and Forecast, by Process (2021-2034)
14.2.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.2.5. Market Revenue and Forecast, by Application (2021-2034)
14.2.6. Market Revenue and Forecast, by End User (2021-2034)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.2.8.2. Market Revenue and Forecast, by Type (2021-2034)
14.2.8.3. Market Revenue and Forecast, by Process (2021-2034)
14.2.9. Market Revenue and Forecast, by Field Strength (2021-2034)
14.2.10. Market Revenue and Forecast, by Application (2021-2034)
14.2.10.1. Market Revenue and Forecast, by End User (2021-2034)
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.2.11.2. Market Revenue and Forecast, by Type (2021-2034)
14.2.11.3. Market Revenue and Forecast, by Process (2021-2034)
14.2.12. Market Revenue and Forecast, by Field Strength (2021-2034)
14.2.13. Market Revenue and Forecast, by Application (2021-2034)
14.2.14. Market Revenue and Forecast, by End User (2021-2034)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.2.15.2. Market Revenue and Forecast, by Type (2021-2034)
14.2.15.3. Market Revenue and Forecast, by Process (2021-2034)
14.2.15.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.2.16. Market Revenue and Forecast, by Application (2021-2034)
14.2.16.1. Market Revenue and Forecast, by End User (2021-2034)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.2.17.2. Market Revenue and Forecast, by Type (2021-2034)
14.2.17.3. Market Revenue and Forecast, by Process (2021-2034)
14.2.17.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.2.18. Market Revenue and Forecast, by Application (2021-2034)
14.2.18.1. Market Revenue and Forecast, by End User (2021-2034)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.3.2. Market Revenue and Forecast, by Type (2021-2034)
14.3.3. Market Revenue and Forecast, by Process (2021-2034)
14.3.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.3.5. Market Revenue and Forecast, by Application (2021-2034)
14.3.6. Market Revenue and Forecast, by End User (2021-2034)
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.3.7.2. Market Revenue and Forecast, by Type (2021-2034)
14.3.7.3. Market Revenue and Forecast, by Process (2021-2034)
14.3.7.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.3.8. Market Revenue and Forecast, by Application (2021-2034)
14.3.9. Market Revenue and Forecast, by End User (2021-2034)
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.3.10.2. Market Revenue and Forecast, by Type (2021-2034)
14.3.10.3. Market Revenue and Forecast, by Process (2021-2034)
14.3.10.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.3.11. Market Revenue and Forecast, by Application (2021-2034)
14.3.11.1. Market Revenue and Forecast, by End User (2021-2034)
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.3.12.2. Market Revenue and Forecast, by Type (2021-2034)
14.3.12.3. Market Revenue and Forecast, by Process (2021-2034)
14.3.12.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.3.12.5. Market Revenue and Forecast, by Application (2021-2034)
14.3.12.6. Market Revenue and Forecast, by End User (2021-2034)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.3.13.2. Market Revenue and Forecast, by Type (2021-2034)
14.3.13.3. Market Revenue and Forecast, by Process (2021-2034)
14.3.13.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.3.13.5. Market Revenue and Forecast, by Application (2021-2034)
14.3.13.6. Market Revenue and Forecast, by End User (2021-2034)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.4.2. Market Revenue and Forecast, by Type (2021-2034)
14.4.3. Market Revenue and Forecast, by Process (2021-2034)
14.4.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.4.5. Market Revenue and Forecast, by Application (2021-2034)
14.4.6. Market Revenue and Forecast, by End User (2021-2034)
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.4.7.2. Market Revenue and Forecast, by Type (2021-2034)
14.4.7.3. Market Revenue and Forecast, by Process (2021-2034)
14.4.7.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.4.8. Market Revenue and Forecast, by Application (2021-2034)
14.4.9. Market Revenue and Forecast, by End User (2021-2034)
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.4.10.2. Market Revenue and Forecast, by Type (2021-2034)
14.4.10.3. Market Revenue and Forecast, by Process (2021-2034)
14.4.10.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.4.11. Market Revenue and Forecast, by Application (2021-2034)
14.4.12. Market Revenue and Forecast, by End User (2021-2034)
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.4.13.2. Market Revenue and Forecast, by Type (2021-2034)
14.4.13.3. Market Revenue and Forecast, by Process (2021-2034)
14.4.13.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.4.13.5. Market Revenue and Forecast, by Application (2021-2034)
14.4.13.6. Market Revenue and Forecast, by End User (2021-2034)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.4.14.2. Market Revenue and Forecast, by Type (2021-2034)
14.4.14.3. Market Revenue and Forecast, by Process (2021-2034)
14.4.14.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.4.14.5. Market Revenue and Forecast, by Application (2021-2034)
14.4.14.6. Market Revenue and Forecast, by End User (2021-2034)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.5.2. Market Revenue and Forecast, by Type (2021-2034)
14.5.3. Market Revenue and Forecast, by Process (2021-2034)
14.5.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.5.5. Market Revenue and Forecast, by Application (2021-2034)
14.5.6. Market Revenue and Forecast, by End User (2021-2034)
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.5.7.2. Market Revenue and Forecast, by Type (2021-2034)
14.5.7.3. Market Revenue and Forecast, by Process (2021-2034)
14.5.7.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.5.8. Market Revenue and Forecast, by Application (2021-2034)
14.5.8.1. Market Revenue and Forecast, by End User (2021-2034)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Architecture (2021-2034)
14.5.9.2. Market Revenue and Forecast, by Type (2021-2034)
14.5.9.3. Market Revenue and Forecast, by Process (2021-2034)
14.5.9.4. Market Revenue and Forecast, by Field Strength (2021-2034)
14.5.9.5. Market Revenue and Forecast, by Application (2021-2034)
14.5.9.6. Market Revenue and Forecast, by End User (2021-2034)
15.1. GE Healthcare
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Siemens AG
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Toshiba Corporation
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Aurora Imaging Technologies, Inc.
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Koninklijke Philips N.V.
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Esaote SPA
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Sanrad Medical Systems Pvt ltd
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Fujifilm
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample